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Binding of dsDNA by cyclic GMP-AMP (cGAMP)
synthase (cGAS) triggers formation of the metazoan
second messenger c[G(20,50)pA(30,50)p], which binds
the signaling protein STING with subsequent activa-
tion of the interferon (IFN) pathway. We show that
human hSTINGH232 adopts a ‘‘closed’’ conformation
upon binding c[G(20,50)pA(30,50)p] and its linkage iso-
mer c[G(20,50)pA(20,50)p], as does mouse mStingR231
on binding c[G(20,50)pA(30,50)p], c[G(30,50)pA(30,50)p]
and the antiviral agent DMXAA, leading to similar
‘‘closed’’ conformations. Comparing hSTING to
mSting, 20,50-linkage-containing cGAMP isomers
were more specific triggers of the IFN pathway
compared to the all-30,50-linkage isomer. Guided by
structural information, we identified a unique point
mutation (S162A) placed within the cyclic-dinucleo-
tide-binding site of hSTING that rendered it sensitive
to the otherwise mouse-specific drug DMXAA,
a conclusion validated by binding studies. Our struc-
tural and functional analysis highlights the unex-
pected versatility of STING in the recognition of
natural and synthetic ligands within a small-molecule
pocket created by the dimerization of STING.INTRODUCTION
The protein TMEM173/STING (stimulator of interferon genes)
(Ishikawa and Barber, 2008; Zhong et al., 2008; Sun et al.,
2009; Burdette et al., 2011) is a central player in the innate
immune response to nucleic acids, particularly cytosolic dsDNA
(reviewed in Burdette and Vance, 2013). STING responds to748 Cell 154, 748–762, August 15, 2013 ª2013 Elsevier Inc.various pathogens, as well as to mitochondrial damage, and its
overactivation may contribute or possibly even trigger the onset
of autoimmune disorders such as systemic lupus erythematosus
(Gall et al., 2012). STING’s role in the immune system is consis-
tent with its higher expression in certain organs such as the
thymus, spleen, and placenta. STING is also expressed in
THP1 human monocytic cells.
An initial screen designed to discover potential regulators of
the type I interferon (IFN) antiviral response identified cyclic
GMP-AMP (cGAMP) synthase (MB21D1/cGAS) as a gene with
broad antiviral effect (Schoggins et al., 2011). Independently,
biochemical fractionation identified cGAS as the metazoan cyto-
solic DNA sensor and synthase of cGAMP, the endogenous sec-
ond messenger that activates the type I IFN pathway (Sun et al.,
2013; Wu et al., 2013). A structure-function study demonstrated
that only one specific isomer of cGAMP, namely c[G(20,50)
pA(30,50)p], was producedby cGAS (Gao et al., 2013). This isomer
of the second messenger contained an unanticipated 20,50 link-
age at the GpA step, a feature subsequently validated by several
independent studies (Diner et al., 2013; Ablasser et al., 2013;
Zhang et al., 2013). Structures of dsDNA-bound cGAS with ATP
and GTP (Gao et al., 2013; Civril et al., 2013), pppGpA dinucleo-
tide intermediate (Gao et al., 2013), and the product c[G(20,50)
pA(30,50)p] (Gao et al., 2013), along with biochemical analysis of
reaction intermediates, provided insights into the stepwise con-
version of GTP and ATP in the first step to pppGpA (Gao et al.,
2013; Ablasser et al., 2013) and subsequent cyclization to
c[G(20,50)pA(30,50)p] (Gao et al., 2013; Ablasser et al., 2013).
The identification of c[G(20,50)pA(30,50)p] as a novel second
messenger generated by dsDNA-bound cGAS in the presence
of GTP and ATP (Gao et al., 2013) has prompted studies of the
role of c[G(20,50)pA(30,50)p] in activating the IFN pathway via the
downstream receptor STING (Diner et al., 2013; Ablasser et al.,
2013; Zhang et al., 2013). Binding of c[G(20,50)pA(30,50)p] to
STING activates a cascade of events whereby STING recruits
and activates IkB kinase (IKK) and TANK-binding kinase
(TBK1), which, following their phosphorylation, activate nuclear
transcription factor kB (NF-kB) and interferon regulatory factor
3 (IRF3), respectively. These activated proteins translocate to
the nucleus to induce transcription of the genes encoding
type I IFN and cytokines for promoting intercellular host im-
mune defense (reviewed in Keating et al., 2011; Paludan and
Bowie, 2013).
Human (h) andmouse (m) STING exhibit 68%amino acid iden-
tity and 81% similarity, with distinct sequence alleles reported in
humans (Diner et al., 2013). (Note that the numbering systems of
human and mouse are offset by one residue, with hSTINGR232
and mStingR231 occupying equivalent positions.) hSTING is
composed of a N-terminal transmembrane domain (aa 1–154),
a central globular domain (aa 155–341), and a C-terminal tail
(aa 342–379). Distinct sequence variants of either mouse or
human STING have been studied with different functional assays
and outcomes, complicating interpretation. Diner et al. (2013)
identified natural variant alleles of STING, namely the R232H
variant to the genome reference of human STING (hSTINGH232,
reference sequence) and the R231A variant of mouse Sting
(mStingA231), which were activated by c[G(20,50)pA(30,50)p] but
not by c[di-GMP] or c[G(30,50)pA(30,50)p]. By contrast, Zhang
et al. (2013) proposed based on structural, calorimetric-based
binding and cellular assays that c[G(20,50)pA(30,50)p] is the
highest affinity ligand for hSTINGR232, even though their in vitro
calorimetric binding measurements did not support their results
seen with IFN induction cellular assays. Ablasser et al. (2013)
investigated the contribution of 20,50- and 30,50-linkages in
cGAMP and concluded that c[G(20,50)pA(30,50)p] was more
potent than c[G(30,50)pA(30,50)] in activating hSTING from human
fibroblasts and THP1 cells, and wild-type mStingR231.
Structural studies have been reported on hSTINGH232 in the
free and c[di-GMP]-bound states. STING forms a symmetrical
dimer in both states with c[di-GMP] bound in a pocket within
the dimer interface and anchored by a network of intermolecular
hydrogen bonds (reviewed in Burdette and Vance, 2013). For all
but one of the c[di-GMP]-hSTINGH232 complexes, the STING
dimer adopts the same V-shaped conformation independent of
the presence of the ligand and also does not completely sur-
round the bound ligand. In the one exception, c[di-GMP]-bound
hSTINGA230/R232 forms an antiparallel b-pleated sheet cap over
the binding pocket on complex formation and this conforma-
tional change further sequesters the bound ligand (Huang
et al., 2012). More recently, the same conformational transition
has been reported on formation of the complex between
mStingR231 and the antiviral drug CMA (Cavlar et al., 2013)
and on formation of the complex between hSTINGR232 and
c[G(20,50)pA(30,50)p] (Zhang et al., 2013).
It is of timely interest to define the structural basis and func-
tional output of ligand binding by hSTING and mSting given
STING’s central role in immunoregulation of the antiviral
response and in eliciting a macrophage-dependent tumoricidal
program (Kim et al., 2013). For example, it remains to be clarified
whether hSTINGR232 is as selective for [G(20,50)pA(30,50)p] as
recently claimed (Zhang et al. (2013), or whether its linkage
isomers are similarly recognized, and to what extent distinct
STING alleles (hSTINGH232 and mStingA231) differentially
respond, as proposed by Diner et al. (2013).DMXAA (5,6-dimethylxanthenone-4-acetic acid, Vadimezan)
was initially identified as a small molecule exhibiting immune
modulatory activities through induction of cytokines and disrupt-
ing tumor vascularization in mouse xenotransplantation models
(Baguley and Ching, 2002). DMXAA, in combination with pacli-
taxel and carboplatin showed promising efficacy and was there-
fore evaluated in a phase II clinical trial against non-small-cell
lung cancer, but subsequently failed in human phase III trials
(Lara et al., 2011). Recently, it has been demonstrated that
DMXAA-induced IFN production by murine macrophages was
impaired by the absence of Sting (Prantner et al., 2012),
suggesting that DMXAA targets the STING pathway. There is a
high-sequence identity between mSting and hSTING, but
DMXAA only activates mSting and has no effect on hSTING
(Conlon et al., 2013), and this has presumably hampered further
therapeutic development of DMXAA as a human drug.
Here, we have undertaken systematic structure-function
studies of mouse and human STING activation by c[G(20,50)
pA(30,50)p], its linkage isomers, c[di-GMP], and antiviral DMXAA
ligand. hSTING was more discriminating toward 20,50-linkage-
containing isomers versus the all 30,50-linkage isomer, and a
unique point mutation (S162A) placed at the cyclic-dinucleo-
tide-binding site in hSTINGH232 and hSTINGR232 rendered
hSTING sensitive to the otherwise mouse-specific drug DMXAA.
These findings are critical to guide future mechanistic studies of
the cytosolic DNA-sensing pathway and the development of
agonists and antagonists of innate immunity as needed for
anticancer and vaccine development, as well as therapies for
autoimmune disorders.
RESULTS
Crystal Structure of c[G(20,50)pA(30,50)p] Bound
to hSTINGH232
The 2.25 A˚ crystal structure of c[G(20,50)pA(30,50)p] bound to the
symmetrical dimer of human STING (G230/H232; aa 155–341;
termed hSTINGH232) is shown in Figure 1A (X-ray statistics in
Table S1). The individual symmetry-related subunits of STING
in a ribbon representation are color-coded in magenta and
yellow, whereas the bound c[G(20,50)pA(30,50)p] is shown in a
space-filling representation. The bound ligand is positioned in
a deep U-shaped cleft between subunits, with the cyclic
sugar-phosphate backbone at the base and the purine rings
pointing upward in a parallel alignment (expanded view in Fig-
ure 1B). The bound U-shaped ligand is further anchored in place
by an overhead cap element formed on complex formation by
an antiparallel four-stranded b-pleated sheet (Figure 2A), such
that the hSTING dimer completely envelops the bound ligand
(Figures 1C and 1D).
The binding pocket is uncharged at its base, whereas both
positive- and negative-charged residues line its walls. The bound
c[G(20,50)pA(30,50)p] is anchored by its purine bases being brack-
eted on either side by Y167 (Figure 1E) and by R238 (whose
position is buttressed by Y240), with R238 aligned in the plane
and hydrogen bonds to the N7 of one purine, while its guanidi-
nium group stacks over the other purine of the bound cyclic dinu-
cleotide (Figures 1E–1G). The bound ligand is further stabilized
through a network of direct andwater-mediated hydrogen bondsCell 154, 748–762, August 15, 2013 ª2013 Elsevier Inc. 749
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Figure 1. Crystal Structure of c[G(20,50)pA(30,50)p] Bound to hSTINGH232 and Details of Intermolecular Contacts in the Complex
(A) The 2.25 A˚ crystal structure of cyclic [G(20,50)pA(30,50 )p] bound to hSTINGH232 (aa 155–341). The symmetrical hSTINGH232 dimer is shown in a ribbon rep-
resentation, with individualmonomers colored inmagenta and yellow. a helices are labeled from a1 to a5. The c[G(20,50)pA(30,50 )p] in a space-filling representation
is bound in the central cavity at the interface between the two monomers.
(B) An expanded view of the c[G(20,50)pA(30,50)p]-binding pocket in the complex. The position of H232 (in green) in a stick representation is labeled in this panel.
(C) A surface representation of the structure of the complex shown in (A).
(D) The view in (C) rotated through 90.
(E–G) Intermolecular contacts in the complex of c[G(20,50 )pA(30,50)p] bound to hSTINGH232. The bound c[G(20,50)pA(30,50)p] is shown in biscuit color, with individual
STING subunits in the symmetrical dimer shown in magenta and yellow. The bracketing of the purine rings of c[G(20,50)pA(30,50)p] by Y167 is shown in (E), and
intermolecular contacts to the base edges and backbone phosphates of the ligand by the subunits of STING are shown in (F) and (G), respectively.
Relates to Figure S1 and Table S1.to the base edges from side chains of hSTINGH232 (Figures 1F
and 1G). Amino acids participating in this network and positioned
above the bound ligand include N242, S241, and V239, which
form water-mediated hydrogen bonds to the O6 of guanosine,
whereas Y163, E260, and Y261 form water-mediated hydrogen
bonds together with a direct hydrogen bond from T263 to the
NH2 group of guanosine (Figure 1F). The edges of the adenosine
base are not involved in hydrogen-bond formation (Figure 1F).
The phosphate backbone and ribose hydroxyls of the cyclic
dinucleotide ring system are additionally stabilized through750 Cell 154, 748–762, August 15, 2013 ª2013 Elsevier Inc.hydrogen bonds. Amino acids participating in this network and
positioned below the bound ligand include S162 and T267
(Figure 1G), with the 30-OH group of the guanosine hydrogen-
bonded to the side chain hydroxyl of S162, whereas no
hydrogen-bonding is observed to the 20-OH of adenosine of
c[G(20,50)pA(30,50)p] in the complex (Figure 1G). The backbone
phosphates of the bound cyclic dinucleotide are recognized by
direct contacts from the guanidinium groups of R238 and
through water-mediated hydrogen bonds from the hydroxyl
groups of T267 and Y240 (Figure 1G).
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Figure 2. Comparison hSTINGH232 Complexes Bound to c[G(20,50)pA(30,50)p] and c[di-GMP]
(A) Details related to alignment and hydrogen-bonding patterns within the four-stranded antiparallel b sheet that forms a cap over the binding pocket on formation
of the c[G(20,50)pA(30,50)p]-hSTINGH232 complex.
(B) Superposition of the c[G(20,50)pA(30,50 )p]-bound structure of hSTINGH232 (aa 155–341) with both subunits in green and c[di-GMP]-bound structure of
hSTINGH232 (aa 139–379) with both subunits in beige (PDB: 4EF4).
(C) Superposition of the c[G(20,50)pA(30,50)p] in green and c[di-GMP] in orange (PDB: 4EF4) in their complexes with hSTINGH232.
(D) An expanded view in stereo of the top right segment of (B) following superposition of the c[G(20,50)pA(30,50)p]-bound structure of hSTINGH232 (both subunits in
green) and c[di-GMP]-bound structure of hSTINGH232 (both subunits in orange) (PDB: 4EF4).
Relates to Figure S1 and Table S1.The four-stranded antiparallel b sheet that forms upon
c[G(20,50)pA(30,50)p]-hSTINGH232 complex formation (Figure 2A)
caps the top of the binding pocket and restricts access to it
(Figure 1A). In addition to hydrogen-bonding between strands
across the four-stranded b-pleated sheet, anchoring at either
end of the sheet is achieved by salt bridges (Figure 2A). It should
be noted that G230 forms part of the outer b strand of this four-
stranded b sheet (Figure 2A).
Comparison of Crystal Structures of c[G(20,50)pA(30,50)p]
and c[di-GMP] Bound to hSTINGH232
One of the published crystal structures of c[di-GMP] bound to
the symmetrical dimer of hSTINGH232 (aa 139–379) (Protein
Database: 4EF4; 2.15 A˚ resolution) (Ouyang et al., 2012) is shown
in Figure S1A (available online) with an expanded view of the
ligand-binding pocket shown in Figure S1B. Note that the loops
protruding over the binding pockets are disordered over half
their lengths in the direction of their tips, whereas the symme-try-related a2-helices form a larger angle in the V-shaped c[di-
GMP] complex (Figure S1A), as compared to the U-shaped
c[G(20,50)pA(30,50)p] complex (Figure 1A) with hSTINGH232.
Indeed, space filling views of the c[di-GMP] complex indicate
that the hSTINGH232 dimer does not encapsulate the bound
c[di-GMP] in its complex (Figures S1C and 1D; termed the
‘‘open’’ STING complex), as it does in space filling views of
the c[G(20,50)pA(30,50)p] complex (Figures 1C and 1D; termed
the ‘‘closed’’ STING complex) with hSTINGH232.
The intermolecular hydrogen bonds stabilizing complex for-
mation in the published structure of the complex of c[di-GMP]
with hSTINGH232 (Protein Database [PDB]: 4EF4) are shown in
Figures S1E and S1F. Notably, the side chains of R238 are disor-
dered, unlike the key recognition role they play in the complex of
c[G(20,50)pA(30,50)p] with hSTINGH232 (Figures 1F and 1G).
The superposition of c[di-GMP] bound to the ‘‘open’’ hSTING
complex (both subunits in beige) with that for c[G(20,50)pA(30,50)p]
bound to the ‘‘closed’’ hSTING complex (both subunits in green)Cell 154, 748–762, August 15, 2013 ª2013 Elsevier Inc. 751
shows large conformational differences in STING between the
two complexes (Figure 2B; rmsd = 3.11 A˚). Indeed, the separa-
tion between the tips of the symmetry-related a2-helices
decreases from approx. 60 A˚ in the ‘‘open’’ complex to approx-
imately 38 A˚ in the ‘‘closed’’ complex. Furthermore, super-
position of the bound c[di-GMP] in beige with that of bound c
[G(20,50)pA(30,50)p] in green establishes that the purine bases
are further apart in the former complex compared to the latter
complex (Figure 2C), and presumably facilitate switching of the
hSTINGH232 from an ‘‘open’’ and more flexible (partly disordered
loops positioned over the binding pocket) conformation in the c
[di-GMP] complex (Figure S1A) to a ‘‘closed’’ andmore compact
(well-defined four-stranded b sheet cap over the binding pocket)
conformation in the c[G(20,50)pA(30,50)p] complex (Figure 1A).
Furthermore, the bound c[G(20,50)pA(30,50)p] (in green) is posi-
tioned slightly deeper in the binding cleft than its bound c[di-
GMP] counterpart (in beige) (Figure 2C, top). Importantly, the
conformational changes propagate to the surface of the STING
protein as shown in a stereo view (Figure 2D), highlighting the
upper right segment of Figure 2B.
Similar ‘‘Closed’’ Conformations Adopted by c[G(20,50)
pA(30,50)p] Bound to mStingR231 and hSTINGH232
We have solved the 1.77 A˚ crystal structure of
c[G(20,50)pA(30,50)p] bound to the symmetrical dimer of
mStingR231 (aa 154–340) (Figure 3A and Table S2). The side chain
of R231 of mStingR231 is shown in green in a stick representation
(Figure 3A). Given the high resolution of this complex, the
network of hydrogen bonds are clearly visible; the 30-OH of gua-
nosine of bound c[G(20,50)pA(30,50)p] makes hydrogen bondswith
the side chain of S161 and two water molecules (Figure 3B). The
guanidinium group of R231 interacts with the backbone phos-
phates of c[G(20,50)pA(30,50)p] through a bridging water molecule
(Figure 3B). Formation of the four-stranded antiparallel b-pleated
sheet acts as a cap over the bound ligand in the complex
(Figure 3A).
We observe excellent superposition of hSTINGH232 (both
subunits in green) and mStingR231 (both subunits in magenta) in
its complexes with c[G(20,50)pA(30,50)p] as shown in Figure 3C
(rmsd = 0.84 A˚). The separation between the tips of symmetry-
related a2-helices are approx. 38 A˚ for both complexes
(Figure 3C). We also observe excellent superposition of the
c[G(20,50)pA(30,50)p] dinucleotide in its complexeswithhSTINGH232
and mStingR231 (Figure 3D). Thus, the same c[G(20,50)pA(30,50)p]-
STING complex is observed whether a His or Arg occupies this
keyposition. Indeed, theR238,S162andT267 inhSTINGH232 (Fig-
ure 1H) and their conserved counterparts R237, S161 and T266 in
mStingR231 (Figure 3B) are involved in similar hydrogen-bonding
interactions with the backbone phosphates and sugar hydroxyl
groups in both complexes.
c[G(20,50)pA(20,50)p]- and c[G(30,50)pA(30,50)p]-Bound
STING Complexes Both Adopt ‘‘Closed’’ Conformations
We also crystallized the two other cGAMP linkage isomers
c[G(20,50)pA(20,50)p] and c[G(30,50)pA(30,50)p] with hSTINGH232
and mStingR231, respectively. We solved a 1.9 A˚ crystal structure
of c[G(20,50)pA(20,50)p] with hSTINGH232 (aa 155–341) (Figure 3E
and Table S1) and a 2.1 A˚ crystal structure of c[G(30,50)pA(30,50)p]752 Cell 154, 748–762, August 15, 2013 ª2013 Elsevier Inc.withmStingR231 (aa 154–340) (Figure 3F and Table S2). The struc-
tures of both complexes adopt the ‘‘closed’’ conformation as
reflected by the positioning of the ligands in the binding pocket,
theseparationbetween the tipsof thea2-helicesbyapproximately
38 A˚, and the formation of the four-stranded antiparallel b sheet
cap over the bound ligands (Figures 3E and 3F).
The crystal structures of c[G(20,50)pA(20,50)p] (in red) and
c[G(20,50)pA(30,50)p] (in green) in their bound complexes with
hSTINGH232 superimpose with an rmsd of 0.59 A˚ (Figure S2A),
with the 30-OH groups of bound c[G(20,50)pA(20,50)p] forming
water-mediated hydrogen bonds to the hydroxyls of S162 and
T267 (Figure S2B). The crystal structures of c[G(30,50)pA(30,50)p]
(in cyan) and c[G(20,50)pA(30,50)p] (in magenta) in their bound
complexes with mStingR231 superimpose with an rmsd of
0.25 A˚ (Figure S2C), with the 20-OH groups of bound c[G(30,50)
pA(30,50)p] forming direct hydrogen bonds to the hydroxyls of
T262 (Figure S2D). The bound c[G(20,50)pA(20,50)p] (in red)
is positioned somewhat deeper in the binding pocket than
c[G(30,50)pA(30,50)p] (in cyan) (Figure S2E).
ITC Binding Studies of hSTINGH232 and Its Mutants with
Linkage Isomers of cGAMP
We recorded the isothermal titration calorimetric (ITC) binding
curves for hSTINGH232 (aa 140–379) with three linkage isomers
of cGAMP as shown in Figure 4A. The binding curves are
exothermic for complex formation with c[G(20,50)pA(20,50)p] (red
circles) and c[G(30,50)pA(30,50)p] (green triangles), and endo-
thermic for complex formation with c[G(20,50)pA(30,50)p] (black
squares; KD = 5.3 mM). The thermodynamic KD, DG, DH, and
TDS parameters for these complexes are listed in Table S3.
We also recorded ITC binding curves for complex formation of
c[G(20,50)pA(30,50)p] with mutants of hSTINGH232 that participate
in intermolecular contacts on complex formation. For this linkage
isomer, cGAMP binding is completely lost (Figure 4B and Table
S4) for the R238Amutant involved in cyclic dinucleotide base N7
and backbone phosphate recognition (Figures 1E, 1F, and 1G),
as well as for the Y240A, N242A, and E260A (significantly
reduced) mutants involved in water-mediated guanosine base
edge recognition (Figure 1F). The impact of mutating the polar
Thr and Ser residues involved in intermolecular hydrogen bond
formation is more nuanced, with no effect on binding affinity
for the T267A mutant, a modest reduction for the S162A mutant
and a more pronounced reduction for the T263A mutant (Fig-
ure 1B). The thermodynamic parameters are listed in Table S4.
ITC Binding Studies of hSTINGR232 and hSTINGA230/R232
with Linkage Isomers of cGAMP
The corresponding ITC-based thermodynamic parameters were
also recorded for complex formation of cGAMP linkage isomers
with hSTINGR232 and hSTINGA230/R232 (aa 140–379) (Figures 4C
and 4D, respectively). The 20,50-containing linkage isomers of
cGAMP exhibited increased binding affinity by about an order
of magnitude for STING variants with R232 compared to H232,
whereas the corresponding binding affinity increase was about
4-fold for the all-30,50 linkage isomer of cGAMP (Table S3), with
endothermic titration patterns observed for all binding curves,
except for an exothermic titration pattern for c[G(30,50)pA(30,50)p]
with hSTINGR232 (Figure 4C). The dissociation constants for
~38 ÅA
B
C
90o
DR237R237
T266
T266S161
S161
Y239Y239
R231R231
L158
E F
Figure 3. Crystal Structure of c[G(20,50)pA(30,50)p] Bound to mStingR231 and Comparison of Its Complex with the Same Ligand Bound to
hSTINGH232
(A) The 1.77 A˚ crystal structure of c[G(20,50 )pA(30,50)p] bound to mStingR231 (aa 154–340).
(B) Intermolecular contacts to the cyclic dinucleotide ring system of the ligand by the subunits of mStingR231.
(C) Superposition of the c[G(20,50)pA(30,50)p]-bound structures of hSTINGH232 (both subunits in green) and mSTINGR231 (both subunits in magenta).
(D) Superposition of the c[G(20,50)pA(30,50)p] in its complexes with hSTINGH232 in green and mSTINGR231 in magenta.
(E) The 1.9 A˚ crystal structure of c[G(20,50)pA(20,50 )p] bound to hSTINGH232 (aa 155–341).
(F) The 2.1 A˚ crystal structure of c[G(30,50 )pA(30,50)p] bound to mStingR231 (aa 154–340).
Relates to Figure S2 and Tables S1 and S2.c[G(20,50)pA(30,50)p] bound to hSTINGR232 and hSTINGA230/R232
were KD = 0.11 mM and 0.16 mM, respectively (Table S3).
ITC Binding Studies of mStingR231 and mStingA231 with
Linkage Isomers of cGAMP
The corresponding ITC-based thermodynamic parameters for
complex formation of cGAMP linkage isomers with mouse
StingR231 (I229/R231; aa 139–378) are plotted in Figure 4E,
with observed KD values similar to those observed forhSTINGA230/R232 (Table S3). The ITC titrations for mStingA231
with the various cGAMP linkage isomers are plotted in Figure 4F,
with the observed KD values listed in Table S3. The dissociation
constants for c[G(20,50)pA(30,50)p] bound to mStingA231 was
KD = 0.34 mM (Table S3).
Crystal Structure of DMXAA Bound to mStingR231
Antiviral small molecules reported to date that target
mSting include 5,6-dimethylxanthenone-4-acetic acid (DMXAA)Cell 154, 748–762, August 15, 2013 ª2013 Elsevier Inc. 753
Figure 4. ITC Data on Binding of cGAMP Linkage Isomers to hSTINGH232 and Its Mutants, as well as to hSTINGR232, hSTINGA230/R232,
mStingR231, and mStingA231
(A and B) ITC binding curves for complex formation between cGAMP linkage isomers bound to hSTINGH232 (aa 140–379) (A) and binding of c[G(20,50)pA(30,50)p] to
mutants of hSTINGH232 (B).
(C) ITC binding curves for complex formation between cGAMP linkage isomers bound to hSTINGR232 (aa 140–379).
(D) ITC binding curves for complex formation between cGAMP linkage isomers bound to hSTINGA230/R232 (aa 140–379).
(E) ITC binding curves for complex formation between cGAMP linkage isomers bound to mStingR231 (aa 139–378).
(F) ITC binding curves for complex formation between cGAMP linkage isomers bound to mStingA231 (aa 139–378).
Relates to Tables S3 and S4.(Figure 5A) (Conlon et al., 2013; Kim et al., 2013) and 10-carbox-
ymethyl-9-acridine (CMA) (Figure S3A) (Cavlar et al., 2013),
with DMXAA and CMA showing species specificity for mouse
but not human STING. The mode of binding of DMXAA and
CMA to mSting is of interest for structure-based design of
agonists and antagonists of hSTING with value as anticancer/
antiviral vaccine adjuvants and anti-inflammatory compounds,
respectively.
We solved the 2.4 A˚ crystal structure of DMXAA bound to
mStingR231 (aa 154–340) (X-ray statistics in Table S2), with the
complex containing two molecules of DMXAA per mStingR231
dimer (Figure 5B). The aromatic rings of the two DMXAAmoieties754 Cell 154, 748–762, August 15, 2013 ª2013 Elsevier Inc.are aligned in parallel but are not stacked on each other. The
details of the intermolecular contacts in the complex are shown
in Figure 5C, with the ketone groups of DMXAA forming direct
hydrogen bonds to the side chain of T266, whereas the carbox-
ylate moieties of the ligand are anchored through direct
hydrogen bonds to the side chains of R237 and T262. In addition,
the adjacent aromatic methyl groups of DMXAA form a hydro-
phobic patch with side chains of L169 and I234 of mSting,
whereas the nonsubstituted aromatic edges (positions 7 and 8)
of DMXAA are positioned opposite I164 (Figure 5C). A four-
stranded antiparallel b-pleated sheet forms a cap over the bind-
ing pocket indicative of formation of a ‘‘closed’’ conformation
A B
R237R237
I234I234
I164I164
T266 T266
T262 T262
L169L169
C
D E~42 Å
R237R237
I234
I234
I164
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T266
T262 T262
L169 L169
S161
S161
S161S161
~38 Å
1
2
3
456
7
8
Y239 Y239
Y239 Y239
Figure 5. Crystal Structure of DMXAA Ligand Bound to mStingR231
(A) Chemical formula of dimethylxanthenone-4-acetic acid (DMXAA).
(B) The 2.4 A˚ crystal structure of two molecules of DMXAA bound to mStingR231 (aa 154–340).
(C) Intermolecular contacts in the complex of DMXAA bound to mStingR231. The two bound DMXAA molecules are shown in biscuit color, with individual mSting
subunits in the symmetrical dimer shown in magenta and yellow. The intermolecular contacts to the polar and nonpolar edges of the DMXAA by the mSting
subunits are shown in two alternate views.
(D) Superposition of the 2.4 A˚ DMXAA-bound structure of mStingR231 (both subunits in biscuit) and of the 1.77 A˚ c[G(20,50)pA(30,50)p]-bound structure of
mStingR231 (both subunits in magenta).
(E) Superposition of c[G(20,50)pA(30,50 )p] in magenta and DMXAA in biscuit in their complexes with mStingR231.
For dose dependence: Data points were determined in triplicate and are depicted as means ± SEM.
Relates to Figure S3 and Table S2.
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on complex formation, consistent also with DMXAA exposure
leading to type I IFN pathway activation via mSting (Conlon
et al., 2013; Kim et al., 2013).
Finally, themStingmoieties bound to DMXAA (both subunits in
biscuit) and to CMA (both subunits in yellow) (PDB: 4JC5) super-
pose well on each other (rmsd = 0.75 A˚) representing the
‘‘closed’’ conformation for both complexes (Figure S3B). By
contrast, the mSting moieties bound to DMXAA (both subunits
in biscuit) and to c[G(20,50)pA(30,50)p] (both subunits in magenta)
show differences upon superposition despite both adopting the
‘‘closed’’ conformation (rmsd = 2.21 A˚) with the separation
between the tips of the a2-helices increasing from approx.
42 A˚ in the former complex to approximately 38 A˚ in the latter
complex (Figure 5D). Superposition of the mStingR231-bound
DMXAA (in salmon) and c[G(20,50)pA(20,50)p] (in magenta) ligands
emphasize the different orientations adopted by these bound
ligands within the same binding pocket (Figure 5E).
cGAMP Isomers Activate Type I IFN Pathway Through
the STING/IRF3 Pathway
To test whether cGAMP isomers elicit an innate immune
response in murine macrophages, we recorded simple dose
response of cultured bone-marrow-derived macrophages
(BMDMs) by addition of increasing concentrations of c[G(20,50)
pA(20,50)p], c[G(20,50)pA(30,50)p] and c[G(30,50)pA(30,50)p] to the
medium, and assaying 4 hr after treatment. Using real-time
reverse transcription PCR (qPCR) analysis to monitor induction
of Ifnb1, Il6, and Ccl5, we determined that exposure of BMDMs
to 20 mM c[G(30,50)pA(30,50)p] elicited the strongest induction
among the three isomers, with Ifnb1, Il6, and Ccl5 mRNA levels
increased by 1024-, 2624-, and 38-fold, respectively, relative to
mock treatment (Figure 6A). Although c[G(30,50)pA(30,50)p] was
the most potent compound, the differences between it and the
other two isomers did not exceed 3-fold. BMDMs isolated from
Irf3–/– mice had reduced induction of Ifnb1, Il6, and Ccl5 upon
exposure to cGAMP isomers, thereby indicating the involvement
of Irf3-dependent type I IFN response pathway (Figure 6B).
Western blot analysis further demonstrated that cGAMP iso-
mers induced phosphorylation of Tbk1 and Irf3 at 2 and 4 hr after
treatment of BMDMs (Figure S4). Consistent with our qPCR
results, incubation of BMDMs with c[G(30,50)pA(30,50)p] also
showed the highest levels of Tbk1 and Irf3 protein phosphoryla-
tion compared to the two other isomers (Figure S4). To test
whether mSting is required for cGAMP-induced Tbk1 and Irf3
phosphorylation, we compared type I IFN response in BMDMs
derived from wild-type and Goldenticket (Gt) mutant mice
(StingGt/Gt), which carry a I199R missense mutation in exon 6 of
the mSting gene resulting in no detectable protein by western
blot analysis of BMDMs (Rasmussen et al., 2011). We observed
that cGAMP-induced Tbk1 and Irf3 phosphorylation was absent
frommSting-deficient cells (FigureS4).Weconclude that cGAMP
treatment of BMDMs triggers type I IFN and proinflammatory
cytokine/chemokine via the mSting/Irf3-dependent pathway.
The strongest responses for mSting were seen for cGAMP deriv-
atives comprising the nonmetazoan all-30,50-linkage isomer pro-
duced by bacteria, which was unexpected, considering the
recent report suggesting that the natural c[G(20,50)pA(30,50)p]
was the highest-affinity ligand for hSTING (Zhang et al., 2013).756 Cell 154, 748–762, August 15, 2013 ª2013 Elsevier Inc.Therefore, we also evaluated hSTING activation and its
dependence on cGAMP isomer concentration. We assayed
type I IFN and chemokine production in human THP1 cells by
ELISA and RT-PCR analysis delivering cGAMP isomers by addi-
tion to the medium without or with Digitonin (Dig) permeabiliza-
tion. In comparison to the murine system, which slightly favored
the bacterial c[G(30,50)pA(30,50)p], the nonnatural c[G(20,50)
pA(20,50)p] stimulated THP1 cells 2.9- or 4.8-fold more effectively
than the metazoan second messenger c[G(20,50)pA(30,50)p] or
c[G(30,50)pA(30,50)p], respectively (Figure 6C and D, left, Table
S5). Measuring transcriptional activation of hSTING-dependent
IFN response genes by the various cGAMP linkage isomers
(Figure 6E) confirmed the ELISA results. As early as 2 hr,
we detected by RT-PCR that c[G(20,50)pA(20,50)p] stimulated
expression of IFNB1 and CXCL10 the most. Digitonin-mediated
cell permeabilization significantly increased and enhanced
sensitivity to all cGAMP isomers in BMDM and THP1 cells (Fig-
ures 6C and 6D, right, Table S5). In THP1 cells, there was no dif-
ference in the EC50 values obtained for c[G(2
0,50)pA(20,50)p] and
c[G(20,50)pA(30,50)p] exposure.
Mutagenesis of hSTING and mSting Identified Amino
Acids Critical for Its Ligand-Binding-Induced IFN
Pathway Activation
To determine the functional importance of individual amino acids
that interacted with c[G(20,50)pA(30,50)p] in the crystal structure,
we generated Ala point mutants of specific residues within
hSTINGH232, as well as of the corresponding mutations in
mStingR231, and tested their activities in human HEK293T cells
using an IFN-sensitive luciferase reporter assay (Burdette
et al., 2011; Gao et al., 2013). STING expression plasmids and
IFNB1 luciferase reporter constructs were cotransfected fol-
lowed by Dig-mediated delivery of cGAMP isomers (Figure 7A),
or cotransfected with wild-type or catalytic mutant (E211A)
cGAS in the absence of exogenous cGAMP addition (Figure 7B)
(Gao et al., 2013). Humanmutant STING variants with amino acid
substitutions of either Y167A, R238A, Y240A, or E260A, as
well as their murine counterparts, were no longer able to stimu-
late the IFN pathway. Notably, hSTINGH232/N242A induced no
measurable IFN reporter activity, whereas mStingR231/N241A
was only slightly impaired in its response. Mutants S162A and
T267A of hSTINGH232 largely retained their normal function,
whereas hSTINGH232/T263A showed reduced activation (Fig-
ure 7A). Dose-response studies of hSTINGH232 (Figure S5)
revealed no significant differences in stimulation between
c[G(20,50)pA(20,50)p] and c[G(20,50)pA(30,50)p] and a lesser
response to c[G(30,50)pA(30,50)p]. However, the hSTINGH232/T263A
mutant shows a gain in sensitivity to c[G(30,50)pA(30,50)p] com-
pared to its response to 20,50 linkage isomers. The S162A and
T267A hSTINGH232 mutants respond similarly to hSTINGH232,
also showing a weaker response to c[G(30,50)pA(30,50)p].
Given the recent report of mSting and hSTING variants with
distinct responsiveness (Diner et al., 2013), we sequenced
hSTING DNAs derived from eight Caucasians and our THP1
cells. All samples encoded R232 in both alleles; additionally
hSTINGTHP1 contained three additional point mutations (H72R,
G230A, and R293Q) as reported before. We compared the
cGAMP-dependent IFN-response for hSTINGH232, hSTINGR232,
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Figure 6. cGAMP Stimulation of the IFN
Pathway in Mouse and Human Cells
(A) BMDMs (13 106) from C57B/6 mice were treated
with increasing concentrations (5, 10, and 20 mM)
of cGAMP linkage isomers, c[G(20,50)pA(20,50 )p],
c[G(20,50 )pA(30,50)p], and c[G(30,50)pA(30,50)p], and
cells were collected at 4 hr after treatment. cGAMP
linkage isomers were provided by addition into
media. Mock treatment control was included. qPCR
analyses of Ifnb1, Il6, and Ccl5 mRNAs were per-
formed.
(B) BMDMs from Irf3–/– and age-matched wild-type
control mice were generated. Cells (1 3 106) were
treated with cGAMP linkage isomers, c[G(20,50)
pA(20,50)p], c[G(20,50)pA(30,50)p], and c[G(30,50)
pA(30,50)p] at a final concentration of 15 mM. cGAMP
linkage isomers were provided by addition into
media. qPCR analysis of Ifnb1, Il6, and Ccl5 mRNAs
were performed.
(C) Murine BMDMs were incubated in media sup-
plemented with indicated concentrations of cGAMP
isomers for 18 hr (left) or for 30 min with and
without Digitonin-mediated permeabilization (right).
Eighteen hours later, IFN-a concentrations in the
supernatant were determined by ELISA.
(D) THP1 cells were incubated in media supple-
mented with indicated concentrations of cGAMP
linkage isomers for 18 hr (left) or for 30 min with and
without Digitonin-mediated permeabilization (right).
CXCL10 concentrations were determined by ELISA
after 18 hr.
(E) Time course of STING-dependent IFN pathway
activation by cGAMP linkage isomers. THP1 cells
were incubated in media supplemented with cGAMP
linkage isomers from 0 to 12 hr without per-
meabilization. IFNB1 and CXCL10 transcriptional
activation was measured by RT-PCR, normalized
against TUBA1B and vehicle control.
Data points in (A) and (B) were determined in tripli-
cate and are depicted as the mean ± SEM. A
representative of two independently performed
experiments is shown. For bar graphs, data points
were determined in triplicate and are depicted as
means ± SEM. Data points in (C) and (D) were
determined in triplicate and are depicted as the
mean ± SEM.Related to Figure S4 and Table S5.
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Figure 7. Mouse and Human STING Mutational Analysis
(A) HEK293T cells were transfected with reporter constructs and human or murine STING expression plasmids as indicated. After 12 hr, cells were digitonin
permeabilized to deliver cGAMP linkage isomers (5 mM concentration, 30 min permeabilization) and incubated for an additional 12 hr, followed by luciferase-
reporter assay.
(B) To gauge STING mutant stimulation by murine cGAS compared to the inactive cGAS mutant E211A, plasmids containing the indicated human or
murine STING variants were cotransfected with either cGAS form and luciferase reporter constructs. Luciferase induction was determined after 30 hr. In this
setting, the transfected plasmids provide the dsDNA stimulus for cGAS activation. Activation is expressed as fold induction in relation to control plasmid
pMAX-GFP.
(C) HEK293T cells were transfected as in (A) and stimulated with c[di-GMP] (5 and 10 mM) following digitonin permeabilization. Luciferase activity was determined
12 hr after stimulation. As negative and positive controls, HEK293T cells transfected with hSTINGH232 were mock-treated (white bar) or stimulated with 5 mM
c[G(20,50)pA(30,50)p] following digitonin permeabilization (green bar), respectively.
(D) HEK293T cells were transfected as in (C) and after 12 hr stimulated with medium containing DMXAA (136 and 266 mM). Luciferase activity wasmeasured after
additional 12 hr.
(E) ITC binding curves for complex formation between DMXAA and mStingR231.
(F) ITC binding curves for complex formation between DMXAA and hSTINGR232/A162 andhSTINGR232/V162.
(legend continued on next page)
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hSTINGTHP1, and mStingR231, and found that the prevalent
hSTINGR232 was several-fold more responsive to all cGAMP iso-
mers when compared to hSTINGH232, with the order of cGAMP
isomer sensitivity remaining the same (Figures 7, S5E, and
S5F). hSTINGTHP1 and wild-type mStingR231 displayed slightly
reduced overall cGAMP sensitivity compared to hSTINGR232.
To complement our mutagenesis study of the cGAMP isomer
response, we tested c[di-GMP] andDMXAA (Figures 7C and 7D).
Although both ligands stimulated mSting, nearly all hSTING
variants were nonresponsive except for hSTINGR232 and
hSTINGTHP-1, which showed a residual response to high concen-
trations of c[di-GMP] (Figures S6B and 7C, respectively). More-
over, mSting mutants defective for recognition of all cGAMP
isomers also failed to recognize c[di-GMP] and DMXAA. Mutants
N241A and T262A of mSting were less responsive to c[di-GMP]
and DMXAA compared to cGAMPs, whereas mSting (T266A)
showed a moderately enhanced recognition of c[di-GMP] over
DMXAA.
S162A Mutant of hSTING is Activated by DMXAA
Strikingly, we found that the single point mutant S162A
enabled recognition of DMXAA by human STING (Figure 7D,
left), while not restoring c[di-GMP] responsiveness (Figure 7C,
left). In both hSTINGH232 and hSTINGR232 background, the
S162A mutation enabled DMXAA recognition with near-iden-
tical dose responses (Figures S6C and S6D). In contrast, the
differences in recognition of cGAMP isomers and c[di-GMP]
were only slightly altered or unchanged compared to the
respective S162 variants (Figure S7B). Noticeably, IFN induc-
tion was not observed in cellular assays for the S162V and
S162I mutants of hSTINGH232 or hSTINGR132, which contain
bulkier hydrophobic amino acids compared to Ala at position
162 (Figure S7A).
ITC-based binding studies confirmed that mStingR231-bound
DMXAA as reported previously (Figure S7E) (Kim et al., 2013),
as did S162A (and S162V) mutants in a hSTINGR232 and
hSTINGH232 context-bound DMXAA (Figures 7F and 7G).
DISCUSSION
Recent Structural Studies Established that hSTINGR232
Adopts a ‘‘Closed’’ Conformation in the c[G(20,50)pA(30,50)
p]-Bound State
Recent structural studies established that hSTINGR232 adopts a
‘‘closed’’ conformation upon association with the cGAS-natu-
rally-produced c[G(20,50)pA(30,50)p] linkage isomer (Zhang et al.,
2013). The structural transition from the ‘‘open’’ conformation
of the free state of STING (Yin et al., 2012; Ouyang et al., 2012;
Shang et al., 2012; Shu et al., 2012) to the ‘‘closed’’ ligand-bound
state (Zhang et al., 2013) was manifested in a 22 inward-shift of
the pair of symmetrically-related a2-helices of STING and
concomitant formation of the four-stranded b sheet cap associ-
ated with the ‘‘open’’ to ‘‘closed’’ transition.(G) ITC binding curves for complex formation between DMXAA and hSTINGH232
Data points in (A to D) were determined in triplicate and are depicted as the mea
(1.5, instead of the expected 1) for the binding curves for A162 mutants of both
Related to Figures S6 and S7, and Table S6.STINGComplexes with cGAMP Linkage Isomers Adopt a
‘‘Closed’’ Conformation Independent of Allelic Variation
at Position 232 of hSTING and Its mSting Equivalent
We observe the same ‘‘closed’’ structures (Figure 3C) for the
complexes of c[G(20,50)pA(30,50)p] bound to hSTINGH232 (Fig-
ure 1A) and mStingR231 (Figure 3A), independent of whether a
His or Arg occupies this equivalent position. Furthermore,
hSTINGH232 adopts the ‘‘closed’’ conformation when in complex
with the all-20,50-linkage isomer (Figure 3E), as does mStingR231
when in complex with the all-30,50-linkage isomer (Figure 3F),
indicating that the ligand-dependent conformational transition
is not specific to any cGAMP linkage isomer, but distinct from
most of the described complexes involving c[di-GMP] and
hSTINGH232. Importantly, the ‘‘closed’’ conformation of STING
in complex with all cGAMP linkage isomers identically reposi-
tions other elements on the outer surface of the STING dimer,
such as the a5-helices and b-barrel elements (stereo view in Fig-
ure 2D), potentially altering protein-interaction surfaces for
potential recognition by regulatory or effector proteins.
Proteins Encoded by Natural hSTING andmSting Alleles
Exhibit Micromolar to Submicromolar Binding Affinities
for cGAMP Linkage Isomers
Our ITC studies of c[G(20,50)pA(30,50)p] and its linkage isomers
showed no significant differences in their binding affinities with
recombinant proteins representing natural alleles of hSTING
andmSting (Figures 4A and 4C–4F, and Table S3). The KD values
for the cGAMP linkage isomers vary between 2.5 and 5.4 mM for
the complexes with hSTINGH232 and between 0.1 and 0.3 mM for
all complexes with hSTINGR232 or mStingR231 (Table S3). The dif-
ference in the binding affinities of individual STING protein alleles
between all cGAMP linkage isomers were largely similar, and
even where different, did not exceed 3-fold. The subtle differ-
ences between cGAMP isomers in binding and activating STING
are recapitulated in our cellular assays of IFN response (Figures
6, 7, and S5), as well as other recently related functional assays
(Ablasser et al., 2013; Zhang et al., 2013).
The Contribution of hSTING Positions 230 and 232 to
cGAMP Linkage Isomer Recognition and Type I IFN
Pathway Activation
Amino acid variation of hSTING at positions 230 and 232 was
reported to affect its sensitivity particularly toward c[di-GMP]
(Diner et al., 2013). Indeed, c[di-GMP] stimulation of HEK293T
cells transfected with hSTINGTHP1, which encodes for A230
and R232, showed reduced IFN-pathway activation (Figure 7C),
while retaining response for all cGAMP isomers (Figure 7A).
Interestingly, hSTINGR232 or hSTINGH232 preferentially acti-
vated with 20,50-linkage-containing cGAMP isomers, whereas
hSTINGTHP1 responded equally well to all linkage isomers under
digitonin-permeabilized conditions (Figure 7A, left). Comparison
of the IFN-responses of hSTINGH232 with hSTINGR232, and
hSTINGR232 with hSTINGTHP1, suggests that R232 and G230/A162 andhSTINGH232/V162.
n ± SEM. We have no explanation at this time for high-stoichiometry N values
hSTINGH232 and hSTINGR232 (F and G).
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are critical for optimal response to 20,50-linkage-containing natu-
ral or unnatural cGAMP isomers. hSTINGH232 was also reported
to phenocopy the behavior of mStingR231A regarding its higher
sensitivity to 20,50-containing cGAMP molecules versus all
30,50-cGAMP and c[di-GMP] (Diner et al., 2013). It is interesting
to note that G230 is one of the few unconserved residues
between human and mouse; the corresponding amino acid in
mSting is an isoleucine. This difference might explain why
there appears to be no preference for any of the cGAMP linkage
isomers or c[di-GMP] with wild-type mStingR231. Position 230
is part of the b sheet cap of the ‘‘closed’’ conformation and
side-chains such as Ala or Ile may subtly change its stability or
degree of closure. However, molecular modeling of an Ala
or Ile substitution for G230 does not indicate any profound struc-
tural changes. Thus it remains unclear whether amino acid vari-
ation at position 230 affects ligand binding, per se, or STING
activation.
Impact of Amino Acid Mutations Surrounding c[G(20,50)
pA(30,50)p] in the ‘‘Closed’’ Conformation of the STING
Complex
The ITC binding studies (Figure 4B and Table S4) and IFN func-
tional assays (Figures 7A and 7B) confirmed that Ala substitution
of structurally identified amino acids that bracket (Y167), and
buttress (Y240) target base edges and backbone phosphates
(R238), and recognize guanosine base edges through direct
and water-mediated hydrogen bonds (N242 and E260) of the
bound c[G(20,50)pA(30,50)p] abolished ligand binding in vitro
and the cellular IFN response. Polar side chains that interact
with the sugar-phosphate backbone of the ring scaffold of
c[G(20,50)pA(30,50)p] in its complex with hSTINGH232 exhibit a
more nuanced effect in both ITC binding studies (Figure 4B
and Table S4) and cellular assays (Figures 7A and 7B). The
T267A mutation, with the potential to disrupt water-mediated
hydrogen bonding to the backbone phosphates of the ligand
(Figure 1G), did not alter in vitro binding affinity (Table S4), while
the S162A mutation, with the potential to disrupt the direct
hydrogen bond to the 30-OH of the guanosine of the bound
c[G(20,50)pA(30,50)p] (Figure 1G), resulted in a modest 2-fold
reduction of in vitro binding affinity (Table S4). By contrast, the
T263A mutation, with the potential to disrupt the direct
hydrogen bond to the NH2 group of guanosine of the bound
ligand (Figure 1F), resulted in a 10-fold reduction of in vitro
binding affinity (Table S4). These data are in agreement with
results of cellular assays measuring IFN response (Figures 7A
and 7B and S5).
Perturbation of Structurally Identified Amino Acids
Coordinating cGAMP Isomers in hSTING Changed Its
Specificity and Sensitivity to Cyclic Dinucleotides
The crystal structure of c[G(20,50)pA(30,50)p] bound by
hSTINGH232 allowed us to identify and functionally confirm the
importance of specific amino acids for recognition of the cGAMP
isomers. Systematic substitution of Ala at positions Y167, R238,
Y240, H242, E260, and T263 of hSTING reduced or abolished
cGAMP-isomer-dependent IFN-pathway activation, whereas
substitutions at positions S162 and T267 did not substantially
affect recognition of c[G(20,50)pA(30,50)p] or the synthetic all-760 Cell 154, 748–762, August 15, 2013 ª2013 Elsevier Inc.20,50-cGAMP isomer (Figures 7A, left, S5B, and S5D). These
results were in a hSTINGH232 background that already exhibited
a reduced affinity for c[G(30,50)pA(30,50)p]. However, we also
performed parallel experiments using mSTINGR231 that ex-
hibited approximately equivalent response to all cGAMP linkage
isomers (Figures 7A, right and S5E). Nearly all amino acid sub-
stitutions that attenuated hSTING activity similarly eliminated
or reduced induction of the IFN pathway by the corre-
sponding murine mutants in a mStingR231 background. Only
mSTINGR231,N241A led to IFN pathway activation but only with
cGAMP linkage isomers containing at least one 20,50 linkage.
Taken together, amino acid variation within the binding pocket
of STING leads to functional changes in the recognition of, and
response to, exposure to cGAMP linkage isomers. We were
able to identify mutations that can reduce or enhance cGAMP-
linkage isomer recognition and also distinguish between 20,50-
linkage-containing cGAMP isomers and the all-30,50-cGAMP.
However, we could not identify any STING variant, natural or
mutant, that could distinguish between c[G(20,50)pA(20,50)p] or
the natural c[G(20,50)pA(30,50)p] linkage isomer.
Contrasting Positions on Activation of hSTING by
20,50-Containing Linkage Isomers of cGAMP
It has been recently proposed by the Z.J. Chen laboratory that
c[G(20,50)pA(30,50)p] is the endogenous high-affinity ligand of
STING (Zhang et al., 2013), a conclusion based on three lines
of experimental information that are contrasted below in light
of data presented in our paper.
First, the Chen laboratory solved the X-ray structure of the
c[G(20,50)pA(30,50)p]-hSTINGR232 (aa 138–379) complex and
demonstrated that hSTINGR232 underwent an ‘‘open’’ to
‘‘closed’’ conformational transition thatwas accompanied by for-
mationof ab sheet lid over thebindingpocket (Zhanget al., 2013).
They interpreted this transition to be reflective of c[G(20,50)
pA(30,50)p] being a high-affinity ligand of hSTING because the
majority of complexes of hSTING with c[di-GMP] retained the
‘‘open’’ conformation. Our position based on structural studies
of a series of complexes that include c[G(20,50)pA(30,50)p]-
hSTINGH232 (Figure 1A), c[G(20,50)pA(30,50)p]-mSTINGR231 (Fig-
ure 3A), c[G(20,50)pA(20,50)p]-hSTINGH232 (Figure 3E), and
c[G(30,50)pA(30,50)p]-mSTINGR231 (Figure 3F) is that all above
complexes form ‘‘closed’’ structures and that the observation
of an ‘‘open’’ to ‘‘closed’’ transition by itself is not necessarily
an indicator for identification of a high-affinity ligand of STING.
Second, there are pronounced differences in the ITC-based
binding affinities reported by the Chen and our laboratories on
complex formation between 20,50-linked isomers of cGAMP and
hSTING. Thus, the Chen laboratory reported KD values of
3.8 nM for the c[G(20,50)pA(30,50)p]-hSTINGR232 and 0.28 mM for
the c[G(20,50)pA(20,50)p]-hSTINGR232 complexes, a difference ap-
proaching two orders of magnitude between these two cGAMP
linkage isomers and was interpreted as the strongest evidence
for justification of c[G(20,50)pA(30,50)p] being a high-affinity ligand
of hSTING (Zhang et al., 2013). By contrast, ITCmeasurements in
our laboratory gave values that differed by less than a factor of
two as reflected in KD values of 0.11 mM for the c[G(2
0,50)
pA(30,50)p]-hSTINGH232 and 0.17 mM for the c[G(20,50)pA(20,50)p]-
hSTINGH232 (Figure 4C and Table S2).
Third, the Chen laboratory found similar EC50 values in their
cellular assays of IFN response for binding of hSTINGR232 to
the various cGAMP linkage isomers, as we did in our cellular
assay measurements, as well as those reported recently from
the Hornung laboratory (Ablasser et al., 2013).
Our position is that the available structural data, our ITC-based
binding parameters and cellular assays from the Chen, Hornung,
and our laboratories are consistent with the 20,50 cGAMP linkage
isomers c[G(20,50)pA(30,50)p] and c[G(20,50)pA(20,50)p] as equally
specific triggers of the hSTING-mediated IFN pathway, and
modestly more effective compared to their c[G(30,50)pA(30,50)p]
linkage isomer counterpart.
Recognition of Antiviral Small Molecules by mStingR231
and the Creation of a hSTING Functional Mutant
Sensitive to DMXAA Activation
Our structural study of the DMXAA-mStingR231 complex (Fig-
ure 5A) as well as the earlier report on the structure of the
CMA-mStingR231 complex (Cavlar et al., 2013) contain two
antiviral small molecules bound within the cyclic dinucleotide
cleft of mSting. The polar atoms of DMXAA form a network of
intermolecular hydrogen bonds involving charged (R237) and
polar (S161, T262 and T266) amino acids of mStingR231, while
its methyl groups form intermolecular contacts with hydrophobic
amino acids (L169 and I234) (Figure 5C), thereby anchoring the
antiviral small molecule within the binding cleft. Importantly, a
subset of the same conserved amino acid side chains lining
the dimeric binding pocket in mStingR231 target a pair of
bound DMXAA ligands and bound c[G(20,50)pA(30,50)p] based
on distinctly different intermolecular contacts (Figures 5C and
1E–1G).
The ligand-binding pocket of mStingR231 adopts a ‘‘closed’’
conformation in both the DMXAA (Figure 5B) and c[G(20,50)
pA(30,50)p] (Figure 3A) complexes, though the pocket is more
V-shaped in the DMXAA complex (Figure 5D). The more
V-shaped ‘‘closed’’ conformation adopted by mStingR231 com-
plex with DMXAA is identical to the one observed for the CMA
complex (Figure S3B).
We were surprised to observe that the S162A mutation
rendered both hSTINGH232 and hSTINGR232 sensitive to DMXAA
binding and activation (Figures 7D and S6). The side chains of
S161 in mStingR231 are positioned in the plane and opposite an
aromatic edge of DMXAA (Figure 5C) and one would predict
that replacement of Ser by Ala in hSTING could favor complex
formation due to either enhancement of intermolecular hydro-
phobic interactions and/or steric constraints. No activation of
the IFN response was observed for the S162V and S162I muta-
tions in a hSTINGH232 and hSTINGR232 context (Figure S7A),
implying the predominance of the steric constraint contribution.
Consistent with this hypothesis, we found that mStingS161A
showed an increased response to DMXAA but not to c[G(20,50)
pA(30,50)p] or c[di-GMP] (Figures 7C and 7D, right).
Importantly, the increased IFN response of hSTINGA162 to
DMXAA observed in cellular assays (Figure 7D) was confirmed
by ITC-based studies, which established binding of DMXAA to
S162A (and S162V) mutants in a STINGR232 (Figure 7F) and
hSTINGH232 (Figure 7G) context (thermodynamic parameters in
Table S6).CONCLUSIONS
In summary, we provide a comprehensive structural, biophysi-
cal, and functional analysis of cGAMP isomer association
with hSTING and mSting. Our data are supportive of a
preference of hSTING for 20,50-linkage-containing cGAMPs that
are modestly more effective compared to their c[G(30,50)
pA(30,50)p] linkage isomer counterpart (see also Ablasser et al.,
2013).
Our structural and functional results highlight the importance
of S162 of hSTING to DMXAA insensitivity, which should poten-
tially enable rational drug design of DMXAA derivatives for the
development of human antitumor, antiviral, and vaccine adjuvant
applications.
EXPERIMENTAL PROCEDURES
Crystallization and Structure Determination
Crystals were grown using the sitting drop vapor diffusion method and diffrac-
tion data collected at synchrotron beam lines. All structures were solved using
PHASER, COOT, and REFMAC programs.
Isothermal Titration Calorimetry
The thermodynamic parameters of binding reactions of STING with cGAMP
isomers and DMXAA were measured by isothermal titration calorimetry using
a MicroCal ITC200 calorimeter at 25C.
Generation of Bone-Marrow-Derived Macrophages
Female Irf3–/–, StingGt/Gt and WT C57B/6 mice were used for the preparation
of bone-marrow-derived macrophages. These mice were maintained in the
animal facility at the Sloan-Kettering Cancer Institute. Bone marrow cells
were cultured in complete medium (CM) in the presence of 5% of supernatant
of L929 mouse fibroblasts as conditioned medium. Cells were plated into
6-well plate (1 million cells per well) at day 7, the day before stimulation.
RT-PCR analysis of THP1 Cells
In RT-PCR analyses, 5 3 105 THP1 cells were plated in 12-well dishes and
incubated overnight. 12.5 mM of cGAMP isomers were applied to the media
and cells were harvested at indicated times. RNA samples were isolated and
cDNA libraries were generated. KOD Polymerase was used to PCR amplify
regions of IFNB1 and CXCL10 and normalized against TUBA1B.
cGAMP Stimulation of Cells
Bone-marrow-derived murine macrophages and THP-1 cells were stimulated
by incubation with cGAMP isomers at indicated concentrations for 18 hr, or by
Digitonin permeabilization (30 min). Cytokines in supernatants were deter-
mined after 18 hr by ELISA.
Luciferase Assay
HEK293T cells were reverse-transfected with STING expression plasmids and
reporter constructs. 12 hr later, DMXAA was added directly, whereas cGAMP
isomers and c[di-GMP] were delivered with digitonin permeabilization. Lucif-
erase expression was determined after another 12 hr, or 30 hr when trans-
fected together with a cGAS-expression plasmid.
See Extended Experimental Procedures for full details of all above sections.
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The following coordinates have been deposited in the RCSB Protein Data
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hSTINGH232 complex (4LOI); c[G(20,50)pA(30,50)p]-mStingR231 complex
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